Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
States allege generic drug manufacturers conspired to artificially inflate prices in lawsuit
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva agrees to $85 million settlement in opioid public nuisance case
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
Teva_Pharmaceuticals | ערוץ 7
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
